Eisai is one of the world's leading research-based pharmaceutical companies. We define our corporate mission as "giving first thought to patients and their families, and to increasing the benefits health care provides," which we call human health care (hhc). With operations in the U.S., Asia, Europe and it's domestic home market of Japan, Eisai employs more than 11,000 people worldwide.

Financial Highlights

Corporate financial information can be found under 'Investor Relations (IR)' at www.eisai.com/ir/index.html.

Please click here to view Eisai Tax Strategy relating to Financial Year ended 31st March 2018

Understanding the future information for investors